October 19, 2015 / 12:36 PM / 3 years ago

BRIEF-Valeant CEO says is in touch with government on investigations

Oct 19 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant CEO says generics with no competitors account for $75 million in revenues quarterly

* Valeant CEO says growth trend emphasizes volume, not pricing

* Valeant CEO says is in touch with government on investigations, declines further comment

* Valeant CEO says sees research and development becoming more of a focus, says with the stock at these prices it will consider share buybacks

* Valeant CEO defends pricing strategy saying many Wall Street analyst reports, media reports are wrong

* Valeant CEO says its patient assistance programs are administered by a reputable third party Further company coverage: (Reporting By Caroline Humer)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below